Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics
| Autor: | Vekemans, J, Moorthy, V, Friede, M, Alderson, MR, Sobanjo-Ter Meulen, A, Baker, CJ, Heath, PT, Madhi, SA, Mehring-Le Doare, K, Saha, SK, Schrag, S, Kaslow, DC |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
Clinical Trials as Topic
Biomedical Research Group B streptococcus Streptococcal Vaccines Infant Newborn Infant Legislation Drug World Health Organization Antibodies Bacterial Article Streptococcus agalactiae Gastrointestinal Tract Technology Transfer Pregnancy Maternal immunization Child Preschool Streptococcal Infections Vagina Humans Female Immunization Vaccine |
| Zdroj: | Vaccine |
| ISSN: | 1873-2518 0264-410X |
| Popis: | Group B streptococcus, found in the vagina or lower gastrointestinal tract of about 10-40% of women of reproductive age, is a leading cause of early life invasive bacterial disease, potentially amenable to prevention through maternal immunization during pregnancy. Following a consultation process with global stakeholders, the World Health Organization is herein proposing priority research and development pathways and preferred product characteristics for GBS vaccines, with the aim to facilitate and accelerate vaccine licensure, policy recommendation for wide scale use and implementation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect